The global lincomycin hydrochloride market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Lincomycin hydrochloride supports in neutralizing the functions of bacteria by disabling their ability of forming necessary proteins which let them survive. Thus, the growing prevalence of infection caused by bacteria is anticipated to spur the market growth. Lincomycin hydrochloride is generally sold under the brand name linocyn. Lincomycin hydrochloride can either be injected in the patient’s body or administered orally. The market growth is also attributed to the growing prevalence of disorders that are caused by a wide range of bacteria such as Streptococcus pneumonia, Propionibacterium acne, Staphylococcus, and various others.
As per the World Health Organization (WHO) pneumonia is the single largest infectious cause of mortalities in children all around the globe. The stats show that the disease killed 740,180 children under the age of 5 in 2019, accounting for 14% of all mortalities of children under 5 years old. Adding to this, the easy availability and the convenient access to lincomycin hydrochloride anti biotic as an over-the-counter medication is further anticipated to propel the global lincomycin hydrochloride market growth.
Market Coverage
• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered-
o By Dosage Form
o By Age Group
o By Application
• Regions covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape: Pfizer Inc., and Merck KGaA, among others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Lincomycin Hydrochloride Market Report by Segment
By Dosage Form
• Capsules
• Tablets
• Injectable
By Age Group
• Pediatric
• Adults
• Geriatric
By Application
• ENT Infections
• Gastrointestinal Infections
• Respiratory Tract Infections
• Skin Infections
• Bone and Joint Infections
Global Lincomycin Hydrochloride Market Report by Region
North America
• US
• Canada
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East and Africa